Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term
NCT03801252Phase 1Completed
- Sponsor
- University of Oklahoma
- Start
- Dec 2018
- Primary completion
- Jun 2021
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, randomised trial in puerperal infection comparing Cefazolin + Azithromycin with Placebo + Placebo (2 arms). Primary endpoints: Number of Participants With Cesarean Delivery at 30 days and Number of Participants With Puerperal Infections at 30 days. Started Dec 2018; status: completed.
02
Drugs
cefazolinazithromycin
03
Conditions
puerperal infection
Beyond the preview
Go deeper on NCT03801252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801252.